Introduction
Cells digest intracellular components in a process called macroautophagy, which helps to meet the cellular demand for essential nutrients and turnover of damaged organelles. In this process, the autophagosomes that have enclosed their targets mature and obtain degradative properties upon fusion with lysosomes. 1 The switch between cell growth and cellular degradation processes is controlled by the mechanistic target of rapamycin complex 1 (MTORC1). The conserved serinethreonine kinase MTOR represents the core of the 2 independently formed complexes MTORC1
and MTORC2, 2-4 which are composed of both shared, and complex-specific subunits. and RPTOR/RAPTOR (regulatory associated protein of MTOR, complex 1), which influences MTORC1 localization and substrate binding. MTORC1 dysregulation is associated with a range of important diseases, such as type 2 diabetes, cancer, and neurodegeneration. 6 Activated MTORC1 inhibits autophagy and proteolytic digestion within lysosomes. [7] [8] [9] [10] During this inhibition the autophagy-initiating ULK (unc-51 like kinase) complex is directly phosphorylated and thereby inactivated by MTORC1. [7] [8] [9] The transcription of autophagosomal as well as lysosomal genes containing CLEAR (coordinated lysosomal expression and regulation) motifs 11 is also inhibited by active MTORC1. Finally, TFEB (transcription factor EB), a helix-loophelix protein containing a leucine zipper motif, is phosphorylated by MTORC1, which prevents its nuclear translocation. [12] [13] [14] [15] The activation of MTORC1 can be triggered by high intracellular amino acid pools or by extracellular-initiated signaling of growth factors and peptide hormones (Fig. S1 ). The presence of essential amino acids is sensed both in the cytoplasm, and in the lumen of lysosomes. Recognition of arginine and glutamine occurs in the lysosome and requires the amino acid transporter SLC38A9
and/or the vacuolar-type H + -ATPase (v-H + -ATPase) complex. [16] [17] [18] [19] Lysosomal amino acids stimulate MTORC1 by activating the lysosome-associated Ragulator complex and the RRAGs (Ras related GTP binding proteins) RRAGA through RRAGD. This machinery then recruits MTORC1 to the cytosolic surface of the lysosomes, a process that is mediated by specific interactions between the MTORC1 component RPTOR/RAPTOR and the RRAGs. 20 The translocation of MTORC1 is necessary for subsequent activation of the MTOR kinase by the lysosome-resident RHEB (Ras homolog enriched in brain). [21] [22] [23] Both the SLC38A9 and the v-H + -ATPase are directly involved in this signaling cascade. v-H + -ATPases are multiprotein complexes belonging to a family of ATP-dependent proton pumps and are responsible for lumenal acidification. They consist of a core machinery of 14 different subunits that are arranged in distinct copy numbers and in 2 main sectors. The peripheral V 1 sector contains 8 subunits, and the membrane-integral V 0 sector is comprised of 6 different subunits. 24, 25 To complement the structure of the v-H + -ATPase, 2 accessory subunits exist in mammalian complexes that are attached to the V 0 sector: ATP6AP1/AC45 (ATPase, H+ transporting, lysosomal accessory protein 1) and ATP6AP2/(pro)renin receptor. Deletion of the Atp6ap2 gene in cardiomyocytes and podocytes results in a significant decrease of the v-H + -ATPase integral membrane proteins [26] [27] [28] implying a chaperone function of ATP6AP2 for the v-H + -ATPase V 0 sector assembly.
The role of the v-H + -ATPase in MTORC1-function is poorly understood. Subunits of the v-H + -ATPase complex interact with the Ragulator complex members LAMTOR1/p18 and LAMTOR2/p14 in an amino acid-dependent manner. 16 Both the v-H + -ATPase complex and
Ragulator complex are required to anchor MTORC1 to the lysosome. 16, 29 Knocking down the ATP6V0C subunit of the v-H + -ATPase complex is associated with a reduced activation of MTORC1 upon addition of amino acids. 16, 17 Until recently, the v-H + -ATPase complex was assumed to be the key factor responsible for amino acid sensing. However, current data argue that the amino acid transporter SLC38A9 is the most critical sensing component. SLC38A9 also interacts with the v-H + -ATPase subunits ATP6V0D1 and ATP6V1B2 19 suggesting a tight coupling of the amino acid transporter and the v-H + -ATPase complex in amino acid sensing. 
Results

ATP6AP2-deficiency in hepatocytes leads to an accumulation of autophagosomes and endocytic vesicles
Lysosomal v-H + -ATPase is a central element regulating MTORC1 signaling and macroautophagy 9, 16, 30 (Fig. S1 ). Because hepatocytes are very active in macroautophagy 31 we set out to study the in vivo consequences of depletion of the v-H + -ATPase complex on macroautophagy and MTORC1 function. We generated conditional knockout (cKO) mice specifically lacking the v-H + -ATPase-accessory subunit ATP6AP2, which is needed for assembly of the v-H + -ATPase V 0 sector (Fig. 1A) . The genetic deletion of Atp6ap2 was induced in previously described Mx1-CreAtp6ap2 floxed mice 32 after treatment of the mice with synthetic double stranded RNA (poly [I:C]) for 5 days. The livers of these animals were analyzed after another 10 days (Fig. S2A ). Already after this relatively short period it became obvious that the livers of the Atp6ap2 cKOs were enlarged by 60% (Fig. S2B, Fig.1B ). Hepatocytes appeared hypertrophic as indicated by hematoxylin & eosin staining (Fig. S2C ). Using ROSA26 EYFP reporter mice crossed with the Mx1-Cre transgenic mice we confirmed that the Mx1-Cre-mediated recombination occurred in hepatocytes and Kupffer cells (Fig. S2D) . Deletion of Atp6ap2 was successful, as revealed by immunoblotting of total liver lysates (Fig. 1C) . Residual levels of ATP6AP2 that were evident are likely due to nontargeted liver endothelial cells (Fig. S2D) . We further observed the concomitant reduction in the concentrations of V 0 subunits TCIRG1/ATP6V0A3 (29 ± 9% remaining), ATP6V0A1 (41 ± 26%), ATP6V0D1 (50 ± 18%) and ATP6V0C (51 ± 12%) (Fig.1C) . Close examination by electron microscopy revealed an accumulation of abnormal vesicles containing partially degraded cytoplasmic material in the Atp6ap2 cKO hepatocytes (Fig. 1D ). The morphology of these vesicles was similar to autophagic vacuoles.
To better define the nature of these vacuoles, immunofluorescence staining of liver sections was performed. MAP1LC3/LC3 (microtubule-associated protein 1 light chain 3) was detected as a marker of autophagosomes and autophagic vacuoles, and SQSTM1/p62 (sequestosome 1) as a marker of autophagic cargo. The numbers of LC3-positive vesicles and SQSTM1 staining were massively increased in the knockout hepatocytes ( Fig. 2A) . Similarly, staining of the late endosomal/lysosomal marker LAMP1 (lysosomal-associated membrane protein 1) was much stronger in the ATP6AP2-depleted cells ( Fig. 2A) . Ubiquitin, which is an indicator for impaired proteasomal and autophagosomal degradation, also accumulated in the knockout samples (not shown). It is of note that LC3 but not SQSTM1 was found in LAMP1-containing autolysosomes (Fig 2A) . The profound accumulation of autophagic and endocytic structures was also observed by immunoblotting with antibodies to LC3, SQSTM1 and LAMP1 (Fig. 2B) . These data conclusively demonstrate that the lack of the v-H + -ATPase complex in hepatocytes leads to dramatic alterations of the endocytic and autophagic systems. The increase in LC3-II and SQSTM1 indicate that autophagy is dysregulated, leading to accumulation of immature and mature autophagic vacuoles.
Decreased autophagic clearance but normal acidification and delivery of endocytic cargo to lysosomes and autolysosomes in cultured ATP6AP2-deficient hepatocytes
Triggered by our observation that SQSTM1 and LAMP1 did not colocalize in ATP6AP2-deficient hepatocytes ( Fig. 2A) and by the reports that a lack of the v-H + -ATPase complex leads to a deficit in acidification in fibroblasts and podocytes, 27, 28 we asked, whether autophagic flux and lysosomes and endocytic cargo transport were fully functional in Atp6ap2 cKO hepatocytes.
To this end, we isolated primary hepatocytes from both control and Atp6ap2 cKO mice 5 days after the last poly (I:C)-injection (Fig. S2A ). These hepatocytes almost completely lacked ATP6AP2 and the TCIRG1/ATP6V0A3, ATP6V0D1 and ATP6V0C subunits of the V 0 sector of the v-H + -ATPase (Fig. S3A) . Similar to the situation with liver lysates, we observed increased levels of LC3, SQSTM1 and LAMP1 in the ATP6AP2-deficient hepatocytes. Analyzing early markers of autophagy, we also noted an increase in autophagy-related proteins ATG12-ATG5 and WIPI2 (WD repeat domain, phosphoinositide interacting 2) (Fig. S3A ). ATG5 immunostaining revealed more punctate staining in the knockout cells (Fig. S3B) The Atp6ap2 cKO hepatocytes were further characterized by functional lysosomal proteolysis, as monitored by DQ ™ Red-BSA fluorescence (Fig. S3D) . Similar to the situation in ATP6AP2-depleted liver, SQSTM1 and LAMP1 did only partially colocalize in immunofluorescence stainings (Fig. S3D ). To monitor if the reduced number of v-H + -ATPase complexes affected endosome-to-lysosome fusion, we offered the cultured hepatocytes BSA-coated 10-nm gold particles in culture medium for 1 h. The delivery of BSA-gold to endocytic and autophagic compartments was monitored by electron microscopy after a 2-h chase period. These experiments revealed that in the Atp6ap2 cKO hepatocytes gold particles reached late endosomes,
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lysosomes and autophagic vacuoles (Fig. S4A,B) , as well as LAMP2-positive compartments ( Fig.   S4C ) with similar efficiency as in control samples. However, this quantification is affected by the much higher abundance, and likely longer half-life, of autophagic and LAMP2-positive compartments in the Atp6ap2 cKO hepatocytes. The autophagic vacuoles that contained the endocytosed gold particles contained partially degraded cytoplasmic material including ribosomes and endoplasmic reticulum. As judged by morphology, the cytoplasmic cargo was less degraded in the cKO hepatocytes compared to the wild-type cells (Fig. S4A) , which is in agreement with the LC3-II blots showing decreased autophagic clearance.
These results revealed that newly ingested endocytic cargo has access to the autophagic and LAMP2-positive compartments in the Atp6ap2 cKO hepatocytes. Further, the colocalization of LC3
and LAMP1 ( Fig. 2A) suggests that autophagosome-lysosome fusion occurs normally in these cells.
In summary, isolated hepatocytes lacking ATP6AP2 display intracellular vesicle fusion along the endocytic and autophagic pathways as well as lysosomal proteolysis by acidic hydrolases.
However, the kinetic of LC3-II degradation was apparently reduced. Our data are in support of the hypothesis that the cellular pathology observed in the liver sections of the Atp6ap2 cKO mice was not caused by impaired fusion or a general defect in acidification but by a decreased autophagic clearance.
Increased MTORC1 activity in Atp6ap2 cKO livers
Because MTORC1 tightly controls macroautophagy and as we have observed an accumulation of autophagic vacuoles and lysosomes in the Atp6ap2 cKO hepatocytes, we predicted that the kinase activity of MTORC1 would be lower in Atp6ap2 cKO livers. To address this question, we analyzed MTORC1 activity after poly (I:C)-mediated induction of ATP6AP2-deficiency (Fig. S2A ). For this purpose phosphorylation of the MTORC1 substrates ULK1 (Ser757), a modulator of early steps of macroautophagy, RPS6KB (ribosomal protein S6 kinase [Thr389]) and the MTORC1 repressor AKT1S1 (Thr246) were determined (Fig. 3A) . Surprisingly, MTORC1 activity remained constant in ATP6AP2-depleted liver and even increased at day 15 after the first induction, whereas
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ATP6AP2 full length and C-terminal fragment as well as V 0 subunit ATP6V0C were clearly reduced in Atp6ap2 cKO livers (Fig. 3A) . In parallel, we monitored the accumulation of lysosome and autophagosome marker proteins. Already at day 7, LAMP1 and LAMP2 concentrations were increased, followed by augmented levels of LC3-I and LC3-II as well as SQSTM1 beginning on day 9 after induction.
We observed that a major fraction of MTOR still localized to lysosomes in the hepatocytes of ATP6AP2-deficient mice (Fig. 3B ). MTOR could furthermore be detected in isolated liver lysosomes from these animals ( Fig. 3C ). In agreement with the increased MTORC1 activity, we found increased levels of the MTOR recruitment factors LAMTOR1, LAMTOR2, RRAGA and RRAGC in the knockout lysosomes ( Fig. 3C ). Translocation of MTORC1 to lysosomes allows the kinase to be activated by the lysosomal RHEB protein.
The increased phosphorylation of the MTOR substrates RPS6KB, AKT1S1 and ULK1 in the ATP6AP2-depleted liver extracts was accompanied by augmented total cellular levels of each of the 3 proteins (Fig. 4A,B) . The overall expression of AKT and MAPK1/ERK2-MAPK3/ERK1 was also increased to 3.7 and 4.8 fold, respectively (Fig. 4A ). This suggests a more general effect on intracellular signaling pathways in the absence of ATP6AP2. TFEB (transcription factor EB) was analyzed as another direct substrate of MTORC1. Surprisingly, increased transcription of the TFEB downstream targets Hexa, Atp6v0d1 and Sqstm1 indicated an elevated activity of TFEB in ATP6AP2-depleted liver (Fig. 4C) . Because increased MTORC1 activity should result in phosphorylation of the transcription factor and its exclusion from the nucleus, we analyzed the cellular distribution of TFEB in control and Atp6ap2 cKO liver. The ratio of nuclear to cytosolic TFEB was slightly elevated in knockout liver (Fig. 4Di ,ii). The nuclear presence of TFEB and an overall increased TFEB expression in Atp6ap2 knockout samples might explain the elevated TFEBdependent gene transcription. Two TFEB independent autophagy-relevant genes, Atg10 and Atg9a, were downregulated, possibly as a compensatory response of the cells ( Under conditions of sufficient nutrient supply (culture medium containing serum, glucose and amino acids) we detected no differences in the degree of autophagy between control cells and ATP6AP2-deficient cells at the ultrastructural level (not shown). These data suggest that in fibroblasts a significant decrease in the v-H + -ATPase level only mildly affects lysosomal acidification and macroautophagy under basal conditions, while no effects were observed under serum and amino acid starvation.
Amino acid-dependent MTORC1 activation requires the presence of ATP6AP2
Our genetically modified cells allowed us to ask whether the downregulation of the v-H + -ATPase complex affects the inactivation and reactivation of MTORC1. In either genotype, withdrawal of both serum and amino acids resulted in an almost complete loss of the phosphorylation of the MTORC1 substrate RPS6KB, as well as a reduction in the phosphorylation of the inhibitory MTORC1 subunit AKT1S1 (Fig. S1, Fig. 6Ai ,ii). Adding back amino acids for two hours led to the reappearance of phosphorylated RPS6KB whereas the AKT-dependent phosphorylation of AKT1S1 did not increase (Fig. 6Ai ,ii). It should be noted that phosphorylation of AKT1S1 is not triggered by addition of amino acids only. Insulin and growth factors also contribute to its phosphorylation at threonine 246 after activation of AKT (Fig. S1ii) . 33 Torin1, a MTORC1 and MTORC2 inhibitor, 34 was able to completely suppress the phosphorylation of RPS6KB, even in the presence of amino acids. In Atp6ap2 knockout cells, the inactivation of MTORC1 was similar to what was seen in control cells. However, the phosphorylation of RPS6KB was clearly reduced upon amino acid stimulation (Fig. 6Ai ,ii).
Our observations using the Atp6ap2 knockout cells argue strongly that the MTORC1 activity depends on the presence of the v-H + -ATPase complex. 16, 17 In the same experiment, we analyzed the MTORC1-dependent phosphorylation status of TFEB. Starvation or Torin1 treatment of wild-type MEFs led to dephosphorylation and presumably nuclear localization of TFEB. [13] [14] [15] 35 Refeeding with amino acids triggered phosphorylation of TFEB in both wild-type and Atp6ap2 knockout MEF cells. However, in the latter cells the level of dephosphorylated TFEB was still higher after 60 and 90 min of refeeding, indicating a reduced MTORC1 activity (Fig. 6AI ).
We further addressed the question of whether the MTORC1 activation depends on the mere presence of the v-H + -ATPase complex, its assembly state or its ability to acidify vesicles. To this end, we treated control cells with BafA1, which blocks proton pump activity and favors the disassembly of the complex, [36] [37] [38] or with saliphenylhalamide A, which inactivates and promotes assembly of the complex. 32, 39 We performed experiments in the presence of a constant concentration of either of these drugs analyzing MTORC1 reactivation at different times after readdition of amino acids (Fig. S6A,B) . We also investigated MTORC1 reactivation after 2 h of amino acid application using different concentrations of either inhibitor (Fig. S6C,D) . These experiments ( Fig. S6A-D) revealed that in wild-type fibroblasts, MTORC1 activation by amino acids is independent of the proton pumping and assembly state of the v-H + -ATPase complex.
We observed that when v-H + -ATPase expression was reduced, addition of free amino acids did not promote phosphorylation of RPS6KB (Fig. 6A ). This finding prompted us to ask whether a similar block in MTORC1 activation is induced in the absence of ATP6AP2 when intracellular amino acids are generated by protein degradation. We therefore offered bovine serum albumin (BSA) to the MEF cells after starvation (Fig. 6B ) and monitored the RPS6KB phosphorylation in control and ATP6AP2-deficient cells. In comparison to the experiment where free amino acids were added, we observed a delayed phosphorylation of the MTORC1 substrate RPS6KB in ATP6AP2-deficient cells, possibly reflecting the uptake and intracellular processing of BSA. In contrast to the free amino acid experiment, the AKT1S1 phosphorylation increased over time, independent of the genotype. This indicates that the intracellular degradation of BSA also affects the AKT-dependent phosphorylation of AKT1S1, a response, which is normally triggered by the activation of receptor tyrosine kinases (Fig. S1ii) .
Insulin-dependent MTORC1 activation occurs independently of the v-H + -ATPase complex
Because insulin and growth factors trigger MTORC1 activation through the AKT pathway (Fig. S1ii ) 40 we wondered if the presence or absence of the v-H + -ATPase complex also affects this signaling pathway. When MTORC1 was inactivated by starvation in control and Atp6ap2 knockout cells, phosphorylation of RPS6KB and AKT1S1 was significantly reduced (Fig. 7A) . Addition of 150 nM insulin for up to 1 h led to the appearance of phosphorylated RPS6KB and AKT1S1 in control fibroblasts (Fig. 7A) . Surprisingly, a similar response was observed in the cells lacking ATP6AP2. In these experiments, inhibition of MTORC1 activity by Torin 1 was used as a negative control, and as expected RPS6KB and AKT1S1 phosphorylation was abolished after Torin 1 treatment. Activation of AKT and MAPK1/ERK2-MAPK3/ERK1 via the insulin receptor was also demonstrated (Fig. 7AI) . In a similar experimental setup, we tested the ability of insulin to trigger MTORC1 activity also in wild-type and ATP6AP2-deficient primary hepatocytes (Fig. 7B) . Again, treatment of serum-and amino acid-deprived cells with insulin-activated MTORC1 in hepatocytes from both genotypes. These data suggest that the v-H + -ATPase complex is dispensable for the stimulation of MTORC1 by insulin.
The full activity of MTORC1 requires activation by lysosomal RHEB (Fig. S1) . 41, 42 Because amino acids are involved in recruiting MTORC1 to the lysosomal surface, we tested if amino acids are also needed for the stimulation of MTORC1 by insulin. We therefore depleted the level of intracellular amino acids by treatment with the lysosomal acidification inhibitor BafA1 and followed the phosphorylation of RPS6KB and AKT1S1 in wild-type and Atp6ap2 knockout cells (Fig. 7C) . In both cell types, depletion of serum and amino acids resulted in inactivation of MTORC1. Addition of insulin led to a reappearance of MTORC1 activity that was blocked in the presence of BafA1. A similar effect was seen when control cells were treated with the proteasomal inhibitors epoxomicin and MG132 (Fig. S7) . Importantly, if amino acids and insulin were added together to inhibitor-treated cells, MTORC1 activity was partially restored (Fig. 7C ).
Our data reveal that insulin could activate MTORC1 independently of the v-H + -ATPase complex. However, this activation depends on intracellular amino acids, possibly derived from degradation by lysosomes and the proteasome.
Discussion
The v-H + -ATPase complex, an integral part of the lysosome and endosome membranes, is traditionally regarded as the proton translocation machinery of these organelles. 25 Although cells lacking the proton pump were unable to signal amino acid availibility to MTORC1, the response to insulin stimulation was still functional. Our conclusion is that in cultured cells and liver tissue the activation state of MTORC1 is controlled by multiple pathways, that include both insulin and growth factor signaling pathways. We speculated that in the absence of functional v-H + -ATPase MTORC1 activity is inhibited, 7, 9, 53 leading to the increased production of autophagosomes. In accordance with this view, we observed that the expression of selected TFEB-downstream genes was upregulated and TFEB was still found in nuclear extracts of ATP6AP2-deficient livers. This might reflect reduced MTORC1-mediated phosphorylation of TFEB. However, in contrast to the hypothesis that MTORC1 is inactive we found normal levels of phosphorylated ULK1, RPS6KB and AKT1S1 in ATP6AP2-deficient mice. The phosphorylation of these substrates suggests a comparable MTORC1 activity in wild-type and Atp6ap2 knockout liver. The decreased phosphorylation of TFEB may be explained by PPP3/calcineurin-dependent dephosphorylation 54 of TFEB or reduced TFEB phosphorylation by other kinases 55, 56 such as recently shown for TFEB-phosphorylation by PRKC/PKC (protein kinase C). 57 Next to the regulation of TFEB nuclear translocation, the increased overall expression of TFEB is one likely reason for the elevated expression of TFEB downstream genes in Atp6ap2 cKO tissue. Our experiments demonstrate that the accumulation of autophagosomes and lysosomes in ATP6AP2-deficient hepatocytes occurs despite normal or even increased activity of MTORC1 and its substrates. This finding is in favor of the view that in liver MTORC1-mediated control of autophagy is not always the dominant factor.
It could well be that-in addition to MTORC1-alternative pathways, such as PDPK1
(phosphoinositide dependent protein kinase 1)-phosphatidylinositol 3-kinase (PtdIns3K) signaling, exist in vivo, which allow MTORC1-independent phosphorylation of RPS6KB. 58 The phosphorylation state of RPS6KB, widely accepted as an reliable readout to monitor MTORC1 activity should therefore be considered with caution. Similarly, an augmented AKT activity may cause the increased phosphorylation of AKT1S1. 33 The liver pathology after ATP6AP2-depletion was very pronounced and secondary effects may have contributed to the observed accumulation of endocytic vesicles in these cells. It seems likely that cytokine-and hormone-mediated signaling 40 TSC2 as an inhibitor of MTORC1 activity is recruited to lysosomes by different conditions of stress or starvation. 65 Only the combined absence of these stimulants will allow the MTORC1 inhibitor to leave its lysosomal localization and permit MTORC1 activity.
Taken together our findings show that the role of the v-H + -ATPase complex in the regulation of autophagy is not exclusively dependent on lysosome-based pathways. The response of the MTORC1 pathway to a lack of ATP6AP2 in liver occurs only after accumulation of autophagomes. This suggests that the proton pump is a central element regulating autophagy in murine cells, whereas PtdIns3K-dependent pathways may be upregulated to provide an effective option for cell survival.
Material and Methods
Antibodies
The following proteins were detected using the denoted antibodies: Phosphorylated (p) 
Immunoblotting and quantification
Cell lysates were prepared as described previously. 32 Proteins were separated on 12.5% SDS-PAGE gels and transferred to nitrocellulose membranes (Whatman, GE Healthcare, 10426994) by semi- Sigma-Aldrich, T0307) per gram body weight, 3 days prior to sacrifice. The purification of tritosomes was performed as described previously 68, 69 using differential centrifugation and separation in a discontinuous sucrose gradient.
Statistical analysis
Statistical significance between genotypes was analyzed via unpaired Student's t-tests using Quantification of the immunoblots was carried out in relation to GAPDH levels. Shown are mean values ± standard errors from 6 to 7 independent animal preparations per genotype. ** P < 0.01, *** P < 0.001 according to unpaired, two-tailed Student´s t test. 
